Search results
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 5 days agoIn an attempt to head off that surgery, doctors may consider another immunotherapy treatment....
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 3 days agoBoth companies reported quarterly earning Thursday, providing insights into how the drug...
Merck stock rises on sales of its blockbuster cancer drug Keytruda
Quartz· 3 days agoMerck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug < ...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 3 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 3 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 2 days agoYoung, who had the melanoma growth cut out of his scalp last August, is one of the first patients to...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 2 days agoSome of the participants will get a placebo shot though none will know what they are receiving....
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters via Yahoo Finance· 3 days agoMerck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling ...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoThe adjustment comes in the wake of Merck's first-quarter results, which not only featured a robust...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 days agoCore earnings per share are also expected to increase in the low double-digit to low teens...